Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
7,243,437
-
Shares change
-
+407,204
-
Total reported value, excl. options
-
$3,537,761
-
Value change
-
+$172,240
-
Put/Call ratio
-
0%
-
Number of buys
-
12
-
Number of sells
-
13
-
Price
-
$0.4873
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q1 2023
As of 31 Mar 2023 Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,243,437 shares of stock of the company.
Largest 10 holders included MMCAP International Inc. SPC, AXS Investments LLC, AdvisorShares Investments LLC, Tejara Capital Ltd, BANK OF MONTREAL /CAN/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, LAIRD NORTON TRUST COMPANY, LLC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, and Royal Bank of Canada.
This table shows 31 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.